A federal judge in Boston ordered a nationwide temporary pause on plans by the National Institutes of Health to substantially slash research overhead payments to
Virtually every U.S. president since Franklin D. Roosevelt has relied on an esteemed scientist or engineer to advise them on some of the nation’s most
Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a
Robert F. Kennedy Jr.’s disclosure on Wednesday that he invested in a gene-editing biotech belies a yearslong track record of voicing concerns about a technology
With President-elect Donald Trump’s inauguration a week away, top officials from his first stint in the White House pointed to a range of ways the
Ionis Pharmaceuticals on Thursday won Food and Drug Administration approval for a therapy that treats patients with a rare and deadly genetic disease that impedes
SAN DIEGO — Bone marrow transplants can be lifesaving for patients with acute myeloid leukemia, but new research reveals how socioeconomic factors create barriers to
On the heels of Donald Trump’s presidential election victory, MIT issued a note of caution to its international students: Assess your winter break travel plans.
After turning cystic fibrosis from a death sentence into a manageable condition for many patients, Vertex Pharmaceuticals is now looking to transform the treatment of
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat amyotrophic lateral sclerosis with a